Endobronchial Blocker Tube (12 models)— 510(k) K251950

Substantially Equivalent

Hangzhou Tappa Medical Technology Co., Ltd.

FDA 510(k) clearance K251950 for Endobronchial Blocker Tube (12 models), Substantially Equivalent on 2026-03-20. Applicant: Hangzhou Tappa Medical Technology Co., Ltd.. Device class: 2.

Summary

Hangzhou Tappa Medical Technology's Endobronchial Blocker Tube comes in 12 listed models, EBT0109 through EBT0205S. They're filed under CBI, differential ventilation tracheal/bronchial tubes (with or without connector).

Class II, 21 CFR 868.5740. Anesthesiology is both the classification panel and the review panel. It was a Traditional 510(k).

Hangzhou Tappa Medical Technology filed from Hangzhou, China. The decision came 268 calendar days after receipt (June 25, 2025 to March 20, 2026).

Clearance details

Device name as filed
Endobronchial Blocker Tube (EBT0109); Endobronchial Blocker Tube (EBT0107); Endobronchial Blocker Tube (EBT0105); Endobronchial Blocker Tube (EBT0109S); Endobronchial Blocker Tube (EBT0107S); Endobronchial Blocker Tube (EBT0105S); Endobronchial Blocker Tube (EBT0209); Endobronchial Blocker Tube (EBT0207); Endobronchial Blocker Tube (EBT0205); Endobronchial Blocker Tube (EBT0209S); Endobronchial Blocker Tube (EBT0207S); Endobronchial Blocker Tube (EBT0205S)
Applicant
Hangzhou Tappa Medical Technology Co., Ltd.
Product code
Product code CBI
Device class
Class 2
Regulation
21 CFR 868.5740
Advisory panel
Anesthesiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Hangzhou, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code CBI

view all

More clearances from Hangzhou Tappa Medical Technology Co., Ltd.

view all

Adverse events under product code CBI

product code CBI
Death
4
Malfunction
594
Total
598

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.